Skip to main content
VERICI DX PLC logo

VERICI DX PLC — Investor Relations & Filings

Ticker · VRCI ISIN · GB00BM8HZD43 LEI · 213800FI5WE4FVQ3G645 IL Real estate activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-05-06 Major Shareholding Noti…
Country GB United Kingdom
Listing IL VRCI

About VERICI DX PLC

https://www.vericidx.com/

Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross specific thresholds. This aligns perfectly with the 'Major Shareholding Notification' category.
2025-05-06 English
Verici Receives Medicare Coverage for Tutivia
Regulatory Filings Classification · 98% confidence The document is a regulatory news announcement (RNS) issued by Verici Dx plc regarding a positive Medicare coverage determination for its Tutivia diagnostic test. It is a corporate announcement of a business development milestone rather than a formal financial report, audit, or proxy statement. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2025-04-10 English
Significant Test Growth with Medicare Pending
Regulatory Filings Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement from Verici Dx plc. It provides a business update regarding Q1 2025 operational performance, including test order rates, revenue guidance revisions, and milestone payments. While it discusses financial metrics, it is an initial announcement of operational highlights rather than a full quarterly or annual report. It fits the definition of a Regulatory Filing (RNS) as it is a news release distributed via the London Stock Exchange's RNS platform.
2025-04-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds). The content details the shareholder (Amati Global Investors Limited), the date the threshold was crossed, and the resulting percentage of voting rights (5.380000%). This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-01-14 English
Update on Local Coverage Determination and Trading
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated October 11, 2024. It contains an 'Update on Local Coverage Determination and Trading' which discusses changes in revenue recognition timelines, cash position, and business outlook. The text concludes with standard boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This structure is characteristic of a general regulatory news service announcement, which is the definition of RNS. It is not a full financial report (10-K, IR), an earnings release (ER), or a specific management discussion (MDA), but rather a broad update disseminated via the regulatory news wire.
2024-10-11 English
Launch of PTRA Assay using Verici Dx's technology
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 4798Y' and concludes with information about RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. The content itself is a brief announcement regarding a licensing agreement milestone (formal launch of an assay) and includes quotes from management. The length is short (4443 chars), and it functions as a general regulatory update/news release rather than a comprehensive report (like 10-K or IR) or a specific transaction report (like DIRS or DIV). Since it is a general regulatory announcement distributed via the RNS system that doesn't fit neatly into the other specific categories (like ER, CT, or MANG), the most appropriate classification is the general regulatory filing fallback category.
2024-07-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.